Skip to main content
. 2018 May 24;103(9):1549–1556. doi: 10.3324/haematol.2018.192419

Figure 3.

Figure 3.

Cumulative incidence of arterial thromboembolism (ATE) according to cancer type. A competing risk cumulative incidence estimator was used. For clarity, only selected tumor entities are compared. A Gray’s test was used to test for differences between cancer types (P<0.001), venous thromboembolism and death-from-any-cause were considered as competing risk event.